A new review highlights the remarkable importance of selenoproteins , a specialized group of molecules that, despite their small size, play a decisive role in shaping cellular fate and maintaining biological balance. These unique proteins, built using the rare amino acid selenocysteine , are essential for protecting cells from damage, regulating metabolism, and guiding critical life-and-death decisions within the body.
At the core of their significance is their ability to manage oxidative stress , a fundamental process linked to aging, chronic disease, and cellular dysfunction. By supporting antioxidant defense systems , selenoproteins help neutralize harmful molecules and maintain redox balance , ensuring cells function efficiently under both normal and stressful conditions.
The review also underscores the complexity of how these proteins are formed. Unlike standard proteins, selenoproteins rely on a sophisticated biological mechanism involving the SECIS element , which enables the precise insertion of selenocysteine during protein synthesis. This intricate system reflects an advanced level of molecular control, highlighting how evolution has refined cellular machinery to achieve high functional precision.
Beyond their structural uniqueness, selenoproteins are deeply involved in regulating multiple forms of cell death , including ferroptosis , a process driven by lipid damage. One protein in particular, GPX4 , emerges as a central defender, preventing destructive chain reactions within cell membranes. Its activity illustrates how selenoproteins act as guardians of cellular integrity, especially under conditions of stress.
The review further reveals the dual nature of these proteins in cancer biology . In some contexts, selenoproteins act as protectors by limiting cellular damage. In others, they may support tumor survival by helping cells adapt to harsh environments. This balance highlights both the promise and complexity of targeting selenoproteins in future therapeutic strategies.
Importantly, the findings emphasize that selenoproteins are not isolated actors but part of a broader network influencing metabolism , hormone regulation , and immune responses . Their widespread involvement positions them as critical regulators of health and disease, with growing relevance in precision medicine.
As scientific understanding deepens, selenoproteins are emerging as powerful targets for innovation, offering new directions for addressing diseases linked to oxidative damage and disrupted cellular processes.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 | Impact Factor: 14.6
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect ( https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Diseases may be made using Editorial Manager ( https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases ( https://x.com/GenesNDiseases )
Reference
Chaoyi Xia, Yifan Wu, Haoming Zhang, Lang Qin, Yiren Hu, Caiyun Fu, Selenoproteins: Minute yet vital players governing cellular fate, Genes & Diseases, Volume 13, Issue 4, 2026, 101938, https://doi.org/10.1016/j.gendis.2025.101938
Funding
Zhejiang Provincial Natural Science Foundation of China LD22H310004
Zhejiang Provincial Natural Science Foundation of China LQN25C070001
Zhejiang Sci-Tech University Research Start-up Fund (China) 24042191-Y
Genes & Diseases